Valategrast hydrochloride

CAS No. 828271-96-1

Valategrast hydrochloride( R-411 | RO-0272441 | RO-27-2441 | R411 | RO 0272441 | RO 27 2441 )

Catalog No. M16076 CAS No. 828271-96-1

Valategrast hydrochloride is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 382 Get Quote
50MG 1962 Get Quote
100MG 2520 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Valategrast hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Valategrast hydrochloride is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.
  • Description
    Valategrast hydrochloride is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.Asthma Discontinued.
  • In Vitro
    Valategrast (hydrochloride) contains a common l-phenylalanine-N-aroyl motif where the carboxylic acid is responsible for binding to the metal ion in the metal-ion-dependent adhesion site (MIDAS).
  • In Vivo
    ——
  • Synonyms
    R-411 | RO-0272441 | RO-27-2441 | R411 | RO 0272441 | RO 27 2441
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    Integrin
  • Research Area
    Inflammation/Immunology
  • Indication
    Asthma

Chemical Information

  • CAS Number
    828271-96-1
  • Formula Weight
    641.411
  • Molecular Formula
    C30H33Cl4N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OCCN(CC)CC)[C@H](CC1=CC=C(NC(C2=C(Cl)C=CC=C2Cl)=O)C=C1)NC(C3=C(C)C=CC=C3Cl)=O.[H]Cl
  • Chemical Name
    2-(diethylamino)ethyl (2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-[4-[(2,6-dichlorobenzoyl)amino]phenyl]propanoate hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sidduri A, et al. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2479-82.
molnova catalog
related products
  • αvβ1 integrin-IN-1

    αvβ1 integrin-IN-1 is a potent and selective inhibitor of αvβ1 integrin (IC50 of 0.63 nM) with antifibrotic effects.

  • CWHM-12

    A novel active RGD peptidomimetic inhibitor of αv integrin with IC50s of 1.8/0.8/61/1.5/0.2 nM for αvβ1/αvβ3/αvβ5/αvβ6/αvβ8; no inhibition on αIIbβ3, α2β1 and α10β1 (>50 uM).

  • Volociximab

    Volociximab (M200) is an IgG4 monoclonal antibody targeting the α5β1 integrin , with antiangiogenic, antitumor and anticancer activity, inhibits the growth of rabbit VX2 tumors and is used to study solid tumors.